Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01589588
Other study ID # H-2-2011-163
Secondary ID
Status Completed
Phase N/A
First received April 26, 2012
Last updated October 9, 2015
Start date April 2012
Est. completion date December 2014

Study information

Verified date October 2015
Source Danish Headache Center
Contact n/a
Is FDA regulated No
Health authority Denmark: GCP-enheden for Region Hovedstaden
Study type Interventional

Clinical Trial Summary

This study will investigate the possible difference in treatment effect between three different oxygen delivery systems in the acute treatment of cluster headaches.


Recruitment information / eligibility

Status Completed
Enrollment 57
Est. completion date December 2014
Est. primary completion date December 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- episodic cluster headache

- regular occurance of attacks and cluster for 2 years

- 2-8 attacks / day

- cluster periods of over 14 days

- duration of current cluster period max 14 days

- ability to differentiate between attacks of CH and other forms of headache

Exclusion Criteria:

- Changes in prophylactic treatment a week before trial

- pregnancy or breastfeeding women

- serious somatic or psychiatric disease

- COLD

- chronic or primary or secondary headache > 14 days / month other than CH

- alcohol abuse

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Open Hudson Mask
Mask type 1 oxygen
Cluster headache mask with 3 L reservoir
Mask type 2 with oxygen
Mask 3
Mask type 3 oxygen
Carnét oxygen demand valve
mask type 3 oxygen
Carnét oxygen demand valve
mask type 3 placebo

Locations

Country Name City State
Denmark Danish Headache Center Glostrup

Sponsors (1)

Lead Sponsor Collaborator
Mads Barløse

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Efficacy Pain relief after 15 minutes of treatment 15 minutes No
Secondary Mask preference subject mask preference 2 days No